More than 80 human X-linked genes have been associated with mental retardation and deficits in learning and memory. However, most of the identified mutations induce limited morphological alterations in brain organization and the molecular bases underlying neuronal clinical features remain elusive. We show here that neurons cultured from mice lacking ribosomal S6 kinase 2 (Rsk2), a model for the Coffin-Lowry syndrome (CLS), exhibit a significant delay in growth in a similar way to that shown by neurons cultured from phospholipase D1 (Pld1) knock-out mice. We found that gene silencing of Pld1 or Rsk2 as well as acute pharmacological inhibition of PLD1 or RSK2 in PC12 cells strongly impaired neuronal growth factor (NGF)-induced neurite outgrowth. Expression of a phosphomimetic PLD1 mutant rescued the inhibition of neurite outgrowth in PC12 cells silenced for RSK2, revealing that PLD1 is a major target for RSK2 in neurite formation. NGF-triggered RSK2-dependent phosphorylation of PLD1 led to its activation and the synthesis of phosphatidic acid at sites of neurite growth. Additionally, total internal reflection fluorescence microscopy experiments revealed that RSK2 and PLD1 positively control fusion of tetanus neurotoxin insensitive vesicle-associated membrane protein (TiVAMP)/VAMP-7 vesicles at sites of neurite outgrowth. We propose that the loss of function mutations in RSK2 that leads to CLS and neuronal deficits are related to defects in neuronal growth due to impaired RSK2-dependent PLD1 activity resulting in a reduced vesicle fusion rate and membrane supply.
Introduction
Coffin-Lowry syndrome (CLS) is a rare syndromic form of mental retardation that shows X-linked inheritance (Hanauer and Young, 2002) . Key features of CLS are growth and psychomotor retardation, characteristic facial and digital abnormalities, and progressive skeletal alterations (Manouvrier-Hanu et al., 1999) . CLS is caused by heterogeneous loss-of-function mutations in the RSK2 (90 kDa ribosomal S6 kinase) gene (RPS6KA3), which maps to Xp22.2 (Trivier et al., 1996) . RSK2 is a serine-threonine protein kinase of 740 aa (90 kDa) that belongs to a family of four members, RSK1-RSK4, which share a highly conserved structure and are widely expressed in mammals and cell types. RSK2 was first described to act at the distal end of the ras-mitogen-activated protein kinase signaling pathway (Frödin and Gammeltoft, 1999) . Different substrates of RSK2 subsequently identified include such transcription factors as ATF4, cFOS, and CREB (Pereira et al., 2010) . Activation of RSK2 is, therefore, thought to influence gene expression and to be involved in cell proliferation and survival.
In human and mouse, the highest levels of RSK2 expression are observed in regions with high synaptic activity, including the neocortex, the hippocampus, and Purkinje cells, which are essential components in cognitive function and learning, suggesting that RSK2 might function in these processes (Zeniou et al., 2002) . Indeed, deletion of RSK2 orthologue S6KII in Drosophila leads to short-term memory defects in a classical olfactory learning paradigm. The Rsk2-null mouse created as a model for CLS develops a progressive osteopenia due to impaired osteoblast function (Yang et al., 2004) . Although no major brain abnormalities are evident at the anatomical and histological levels in Rsk2-knockout (Rsk2-KO) mice, behavioral studies reveal profound retarda-tion in spatial learning and a deficit in long-term spatial memory (Poirier et al., 2007) . On the other hand, a number of subtle neuroanatomical abnormalities have been found in CLS individuals (Hunter, 2002; Stephenson et al., 2005) . For example, a morphometric MRI-based study of CLS brain morphology has revealed a reduced total brain volume that appeared to be correlated with the severity of CLS outcome (Kesler et al., 2007) . Altogether, these observations favor a role for RSK2 in the development and plasticity of neuronal circuits, but the molecular basis for this function remains elusive.
In agreement with a direct role of RSK2 in neurotransmission, we recently described RSK2 as a critical upstream signaling element in the activation pathway of phospholipase D1 (PLD1), which produces fusogenic lipids required for calcium-regulated exocytosis (Zeniou-Meyer et al., 2008 . Considering that both PLD1 and PLD2 have been implicated in the regulation of neurite growth in neural cell lines and neural stem cells (Kanaho et al., 2009) , we decided to investigate whether mutations or loss of expression of RSK2 interfere with the growth and development of neurons by modulating PLD activity. Using cultures of cortical neurons from transgenic mice models and PC12 cells, we demonstrate that RSK2 is an essential modulator of PLD1 activity and is required for neurite outgrowth.
Materials and Methods
Materials. Antibodies anti-␤-tubulin (Cell Signaling Technology), anti-RSK2 (Santa Cruz Biotechnology), anti-PLD1, anti-SNAP25, anti-ERK, anti-phospho-ERK, anti-phospho-RSK (New England BioLabs), antimicrotubule-associated protein 2 (MAP2) (Sigma-Aldrich), and antiphospho-PLD1 (Thr-147; Cell Signaling Technology) were used. The RSK inhibitor BI-D1870 was obtained from Enzo Life Sciences, the PLD1 inhibitor CAY-10593 (CAY-93) from Interchim, DRAQ5 from Biostatus, and neuronal growth factor (NGF), phaloïdin-tetramethylrhodamine B, and 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) from (Sigma-Aldrich).
Plasmids and siRNA sequences have been described previously (Corrotte et al., 2006; ZeniouMeyer et al., 2007 ZeniouMeyer et al., , 2008 . pHluorin-VAMP-7 was provided by Dr. T. Galli (Institut Jacques Monod, Paris).
Animals and tissue dissection. Pld1 Ϫ/Ϫ and Rsk2 Ϫ/Ϫ mice were described previously (Yang et al., 2004; Elvers et al., 2010) . All experiments were performed in accordance with the European Community's Council Directive of November 24, 1986 (86/609/EEC) . Every effort was made to minimize the number of animals used and their suffering.
Cell culture and NGF treatment. Cortical neurons were cultured from embryonic day 15 mice of either sex in Neurobasal medium (Invitrogen) supplemented with 2% B-27, 1% GlutaMAX, and 1% Pen/Strep. Low-density cultures were plated on poly-L-lysine (SigmaAldrich)-coated glass coverslips at 25,000 neurons/cm 2 . For the analysis of early neurite outgrowth (DIV1-DIV3), random images were taken of the cultures using a 63ϫ lens on a Leica SP5II confocal microscope. Cultured 80% confluent PC12 cells were transfected by Lipofectamin 2000 (Lam et al., 2008) . When indicated, drugs were applied 30 min before NGF treatment. NGF was applied to cells 48 -72 h after transfection at 50 ng/ml and added freshly every 24 h. Cells developing neurites were counted and the neurite length measured using ImageJ software with Simple neurite tracer plug-in. Determination of PLD activity. PC12 cells were incubated with medium or medium containing the different drugs for 30 min and then incubated for 30 min with NGF (50 ng/ml). PLD activity was measured as described previously (Lopez et al., 2012) . The PLD activity of the cell not treated with NGF was subtracted. Data are given as the mean of six determinations performed on Ն3 different cell preparations Ϯ SEM.
Western blot and immunoprecipitation. After treatment, cells were lyzed and proteins were resolved by SDS 4 -12% PAGE. Proteins were transferred to nitrocellulose membranes as described previously (de Barry et al., 2006) . Detection was performed by chemiluminescence by using the Super Signal West Dura Extended Duration Substrate (Pierce). For immunoprecipitation, protein extracts were prepared in lysis buffer (50 mM HEPES, 3 mM EGTA, 3 mM CaCl 2 , 3 mM MgCl 2 , 80 mM KCl, 0.1% Triton X-100, 0.1% sodium deoxycholate, 1 mM sodium orthovanadate, 40 mM NaF, and protease inhibitor mixture; Sigma-Aldrich). Five hundred micrograms of total protein were used. Quantification of Western blots was performed as described earlier (Béglé et al., 2009) .
Immunocytochemistry. Neurons and PC12 cells were fixed and further processed for immunofluorescence as described previously (Vitale et al., 1998) . Stained cells were visualized with a Leica SP5II confocal microscope. Colocalization level of Spo20p and SNAP25 was estimated as described previously (Zeniou-Meyer et al., 2007) . Quantification of RSK2 and PLD1 colocalization was performed for each condition on 30 selected regions of interest on the membrane ruffles from 15 cells using ImageJ.
Live cell imaging and total internal reflection fluorescence microscopy. PC12 cells were transfected with PLD1-green fluorescent protein (PLD1-GFP) or VAMP-7-pHluorin and incubated with NGF overnight. The next day, optical recordings were performed using a Axiovert 200 with Moane TIRF-2 total internal reflection fluorescence (TIRF) microscope (Zeiss) equipped with a 100ϫ objective, a 1.45 numerical aperture, and an ImageM camera (Hamamatsu). Temperature was maintained at 37°C during recording. Under the conditions of observation used, one pixel corresponded to 160 nm. Stream acquisitions were performed at 1.44 Hz for 3 min with an exposure time of 280 ms. Selective excitation was obtained using argon laser lines at 488 nm. Optical bandpass filters (500 - 
Results

RSK2 and PLD1 are involved in neurite outgrowth
Axon and dendrite outgrowth are critical events in the establishment of neuronal networks during brain development. This complex process is not fully understood, but the forming neurons appear to go through at least three morphologically distinct steps (Craig and Banker, 1994) : Stage 1, formation of lamelliopodia; Stage 2, sprouting of multiple neurites similar to each other in structure and composition; and Stage 3, differentiation of neurites into either axons or dendrites (Fig. 1A) . The establishment of synapses and networks are the last steps in the formation of mature neurons. We cultured cortical neurons from Rsk2-null mouse and found a dramatic delay in this process compared with neurons cultured from WT littermates (Fig. 1B) . At 24 h of culture, a significant proportion of neurons from Rsk2 Ϫ/Ϫ mice were still in the first stage of development. At 72 h, when most neurons of WT mice had progressed through the second and third phases of development, 20% of Rsk2 Ϫ/Ϫ neurons were still at Stage 1 (Fig. 1B) . Conversely, the proportion of neurons reaching Stage 3 in the Rsk2-null mice was significantly reduced (Fig.  1B) . Since PLD1, but not PLD2, contains a RSK2 phosphorylation site at Thr147, we also examined cortical neurons from Pld1-null mouse. As illustrated in Figure 1B , Pld1 Ϫ/Ϫ neurons displayed a delay in outgrowth that was very similar to that of Rsk2 Ϫ/Ϫ neurons. Additionally, the average axonal length in control neurons (143 Ϯ 7 m) was reduced by 32% in Rsk2 Ϫ/Ϫ neurons and by 29% in Pld1 Ϫ/Ϫ neurons. To further test the hypothesis that PLD1 plays a role in neurite outgrowth and may thereby be involved in neuronal development, we investigated the effect of PLD1 knockout on subsequent neuronal development hallmarks using the Pld1 Ϫ/Ϫ mice. Dendritic morphogenesis is an important step for the establishment of neural circuitry. The number of primary dendrites arising from the cell body, higher-order dendrites emerging from primary dendrites, and dendritic branching patterns appear to be critical for neuronal function (Jan and Jan, 2010). Pld1 KO affected dendritic branching at 10 days in vitro (DIV), as observed by Sholl analysis (Fig. 2 A, B) , a standard assay for measuring dendritic complexity (Jaworski et al., 2005). Although we found no significant differences in the number of primary branching dendrites, the number of secondary branching dendrites was significantly reduced in neurons cultured from Pld1 Ϫ/Ϫ mice ( Fig.  2C ). Because the dendritic tips were at the terminal branches and reflected the complexity of dendrites, we next analyzed whether the number of dendritic tips was altered in neurons lacking PLD1. Consistent with the reduction in secondary dendritic branching, the number of dendritic tips was decreased in neurons from Pld1 Ϫ/Ϫ mice (Fig. 2C ). Dendritic spines are key features for neuronal development and synaptic function. For instance, the density and morphology of dendritic spines are directly correlated with their functions. To test the possibility that PLD1 is involved in dendritic spine development, we used actin labeling to outline dendritic spines in cultured cortical neurons (Fig. 2D ). In agreement with the possibility that PLD1 is involved in neuronal development, we found a significant decrease in total spine density in 10 DIV Pld1 Ϫ/Ϫ neurons (Fig. 2E ). In fact, this reduction in spine density specifically affected mushroom and branched spines, which are the forms of mature spines (Fig.  2F) . These observations suggest a reduced level of functional synapses in neurons lacking PLD1. Although early pharmacological approaches have postulated that PLD1/2 could be involved in neurite outgrowth, this is the first report using Pld1-null mouse that validates this idea and supports the concept that this may have a long-term effect on neuronal development.
NGF stimulation triggers RSK2-dependent phosphorylation and activation of PLD1 in PC12 cells
The possible interplay between RSK2 and PLD1 in neurite outgrowth was further investigated using the classical NGFinduced neurite outgrowth assay in pheochromocytoma PC12 cells. Effective silencing of PLD1 and RSK2 was obtained in PC12 cells (Fig. 3A, insets) . Based on transfection efficiencies, we calculated that the silencing level for PLD1 and RSK2 was 87 and 93%, respectively, in agreement with our previous observations in PC12 cells (Zeniou-Meyer et al., 2007 . Both reduction of RSK2 or PLD1 expression by siRNA-silencing experiments affected neurite outgrowth in response to NGF stimulation (Fig. 3A) . Rescue experiments performed by coexpressing RSK2 or PLD1 constructs insensitive to siRNA ruled out possible off-target effects of the siRNAs (Fig. 3A) . Similar results were obtained using pharmacological inhibitors. NGF-induced neurite outgrowth in PC12 cells was potently inhibited by the RSK inhibitor BI-D1870 (Sapkota et al., 2007) and by the dual PLD1/ PLD2 inhibitor FIPI (Su et al., 2009 ) and the PLD1 isoformspecific inhibitor CAY-93 (Lewis et al., 2009; Fig. 3B) . Note that we did not observe an additive effect of the RSK2 and PLD1 inhibitor, suggesting that the two proteins may control the same pathway during neurite outgrowth.
To dissect the signaling pathway linking NGF stimulation to RSK2 and PLD1, PC12 cells were challenged with NGF for different periods of time and phosphoproteins were detected in cell extracts by Western blotting. NGF stimulation produced progressive and parallel increases in the level of phosphorylated RSK2 and PLD1, reaching a plateau at 15 min (Fig. 4) . Interestingly, the RSK inhibitor BI-D1870 was found to block in a dosedependent manner the NGF-induced phosphorylation of PLD1 (Fig. 4) , in agreement with the idea that PLD1 might be a target activated by phosphorylated RSK2 upon NGF stimulation.
The intracellular distribution of overexpressed RSK2 and PLD1 is depicted in Figure 5 . In resting PC12 cells, RSK2 displayed a nuclear and perinuclear distribution, whereas PLD1 was mostly found in the periphery of the nucleus most likely associated with vesicular structures (Fig. 5A) . A 30 min stimulation with NGF induced a change in PC12 cell morphology (ruffles) and caused a partial redistribution of both PLD1 and RSK2 to the cell periphery, where the two proteins appeared to colocalize (Fig.  5A, arrowheads) . Quantification revealed that at membrane ruffles, 94.2 Ϯ 1.0% of RSK2 and PLD1 signals colocalized. This recruitment of GFP-PLD1 to the periphery of NGF-treated cells is in line with the ability of PLD1 to cycle from vesicular structures to the plasma membrane Du et al., 2003) . Coimmunoprecipitation experiments of endogenous RSK2 and PLD1 confirmed that both proteins were associated in the same complex in NGF-treated cells (Fig. 5B) . Additionally, we found that NGF induced a potent increase in PLD activity (ϳ80%) that was completely blocked by the broad-spectrum PLD inhibitor FIPI and strongly inhibited by the specific PLD1 inhibitor CAY-93, suggesting that NGF mainly stimulated type 1 PLD activity (Fig. 5C) . RSK2 inhibition by BI-D1870 also significantly prevented NGF-induced PLD1 activation (Fig. 5C ). These results suggest that NGF stimulation triggers the recruitment of RSK2 and PLD1 to growing neurite endings where activated RSK2 phosphorylates and activates PLD1.
NGF-evoked neurite outgrowth is mediated by RSK2-induced PLD1 phosphorylation on Thr-147
RSK2 has been shown to activate PLD1 by phosphorylating Thr147 residue (ZeniouMeyer et al., 2008) . To reinforce the idea that the phosphorylation of PLD1 by RSK2 is important for neurite outgrowth, we measured neurite length after NGF treatment in PC12 cells expressing RSK2 siRNAs and attempted to rescue growth with WT or mutated PLD1 proteins. In cells with a reduced RSK2 level, neither expression of PLD1 WT nor PLD1(T147A), a phosphorylation-deficient mutant, restored neurite outgrowth (Fig. 6) . In contrast, expression of the phosphomimetic PLD1(T147E) mutant restored growth despite the reduced RSK2 level. Note that the dual phosphomometic and kinase dead mutant PLD1(T147E-K898R) was unable to rescue neurite outgrowth from KSK2 knockdown PC12 cells (Fig. 6) , suggesting that the lipase activity of PLD1 is required for the rescue effect. These results are consistent with a sequence of events in which NGF leads to RSK2 phosphorylation and activation, which in turn phosphorylates PLD1 on Thr147, stimulating PLD1 activity and promoting neurite outgrowth.
Phosphatidic acid synthesis at sites of neurite outgrowth PLD1 is responsible for the production of phosphatidic acid (PA). Thus we examined PA synthesis in PC12 cells using the PA-binding domain of Spo20p fused to GFP as a PA sensor (Zeniou-Meyer et al., 2007; Kassas et al., 2012) . In resting cells, Spo20p-GFP was present in the nucleus, but after a 30 min application of NGF, a significant fraction was recruited to the plasma membrane, where it colocalized with SNAP25 ( Fig. 7 A, B) . PLD1 inhibition (by CAY-93), but also RSK2 inhibition (by BI-D1870), completely prevented the recruitment of Spo20p to the cell periphery, highlighting the importance of RSK2 in NGF-induced PLD1 activation and PA synthesis at the plasma membrane (Fig.  7 A, B) . Interestingly, Spo20p expression in PC12 cells strongly reduced the number and length of the NGF-induced neurites ( Fig. 7C) , most likely by quenching PA and preventing its function in neurite outgrowth. In agreement with this model, expression of the mutant Spo20p(L67P), which is unable to bind to PA (Zeniou-Meyer et al., 2007) , failed to affect neurite outgrowth (Fig. 7C ). The molecular mechanism by which PA may control neurite outgrowth has yet to be elucidated. However, it might be related to the proposed role of PA in vesicular trafficking, i.e., a promoter of vesicle fusion with target membranes through biophysical changes in membrane topology and/or recruitment and activation of fusion promoters at the fusion site ).
Neurite initiation entails significant surface area expansion. It involves distinct pathways that require coordination between the actin cytoskeleton and fusion of vesicle to provide membrane to the growing endings (D'Allessandro et al., 2010; Gupton and Gertler, 2010) . In NGF-treated PC12 cells, we observed anterograde and retrograde movement of PLD1-positives vesicles in neurites and occasionally the directional movement of PLD1-positive vesicles toward the tips of the growing neurites (Fig.  8A) . To further characterize these PLD1-positive vesicles in PC12 cells, we tested for the presence of the vesicular SNARE proteins VAMP-2, VAMP-4, or tetanus neurotoxin insensitive VAMP/VAMP-7 (TiVAMP/VAMP-7). As shown in Figure  8B , PLD1 did not colocalize with VAMP-2, colocalized only partially with VAMP-4 in the perinuclear region, but strongly colocalized with VAMP-7. Interestingly after NGF treatment, VAMP-7 and PLD1 were found at the tip of growing neurites (Fig. 8C) . VAMP-7 vesicles are known to play a major role in neurite outgrowth (Martinez-Arca et al., 2000) . To probe the idea that RSK2-activated PLD1 may play a critical role in the fusion of VAMP-7 vesicles at the tip of growing neurites, we recorded the fusion of pHluorin-VAMP-7 vesicles by TIRF microscopy (Burgo et al., 2012) . When the pHsensitive GFP variant pHluorin is fused to the luminal domain of VAMP-7, its fluorescence is significantly quenched due to exposure to the acidic pH of the vesicle lumen. Upon exocytosis, luminal proteins are exposed to the extracellular medium and become fluorescent. In PC12 cells, NGF treatment triggered successive fusion events of VAMP-7 vesicles at the neurite growth cones (Fig. 9A) . Treatment with the PLD1 and RSK inhibitors significantly reduced the frequency of these fusion events as revealed by the increase in the intervals between successive events (Fig. 9B,C) . This observation supports the idea that RSK2-stimulated PLD1 activity is functionally involved in VAMP-7 vesicle incorporation at the growing endings of developing neurites. Finally, we silenced VAMP-7 in PC12 cells and examined the effect of the phosphomimetic mutant PLD1-T147E expression on neurite outgrowth. Neurite length in PLD1-T147E-expressing cells was 82.69 Ϯ 4.88 m compared with 37.67 Ϯ 3.47 m (p Ͻ 0.001) in cells expressing both siVAMP-7 and PLD1-T147E. In other words, reducing the expression of VAMP-7 severely impaired the ability of the phosphomimetic PLD1 mutant to promote neurite outgrowth, in line with the idea that VAMP-7 is an effector for RSK2/PLD1 in the process of neurite growth.
Discussion
Despite intensive research on CLS, the relationship between genotype and phenotype remains poorly understood. Specific physiolog- ical roles of RSK2 are also unclear and little is currently known about the cellular effects of RSK2 in neurons. Behavioral studies in Rsk2-KO mice revealing normal motor coordination, but a profound retardation in spatial learning and a deficit in long-term spatial memory, provide evidence that RSK2 has similar roles in mental functioning in both mice and humans (Poirier et al., 2007) . Although Rsk2-KO mice show no obvious brain abnormalities at the anatomical and histological levels, we show here that cortical neurons cultured from these mice display significant developmental delay. At 3 d of culture, only 20% of the Rsk2-KO mice neurons developed an axon compared with 60% in WT neurons. These observations are in line with the recent finding that Rsk2 knockdown perturbs the differentiation of neural precursors into neurons (Dugani et al., 2010 ). Since we previously identified PLD1 as a target of RSK2 in neuroendocrine-regulated exocytosis (Zeniou-Meyer et al., 2008 , we decided to investigate the possibility that PLD1 could be involved in RSK2-mediated neurite outgrowth. In agreement with this idea, we found that cortical neurons cultured from Pld1-KO mice displayed a significant delay in development comparable to neurons from Rsk2-KO mice. Using the classical NGF-induced neurite outgrowth assay in PC12 cells, we show that RSK2 colocalizes, phosphorylates, and regulates PLD1 activity in response to NGF stimulation. NGF-induced neurite outgrowth is severely impaired in RSK2-depleted cells, but this can be rescued by expressing a phosphomimetic mutant of PLD1. Finally, both RSK2 and PLD1 inhibitors inhibit PA synthesis and VAMP-7 vesicle fusion at growth cones in response to NGF. Together, our findings reveal a mechanism in which RSK2-mediated PLD1 activation and subsequent PA synthesis favor vesicular fusion and membrane supply required for neurite outgrowth. Previous experiments in PC12 cells suggested that RSKs might be involved in neurite outgrowth since overexpression of a catalytically active mutant of rat RSK1 was able to promote neurite growth in the absence of NGF (Silverman et al., 2004) . This effect was, however, not reproduced by the overexpression of a catalytically active mutant of mouse RSK2, suggesting that only RSK2 may be intimately linked to the NGF-induced differentiation process in PC12 cells. Nevertheless, the fact that we found only a partial block of neurite outgrowth in Rsk2-KO neurons, suggests that endogenous RSK1 may be able to partially compensate the loss of RSK2 in neurons. PLD activity has been implicated in neurite outgrowth in various neuronal models for over a decade, but most of these findings rely on the use of ethanol as a nonspecific inhibitor of PA synthesis and in most cases the PLD isoform involved was not identified. Using for the first time a combination of KO mice model, a gene silencing approach, and the recently described isoform-specific PLD inhibitors, we demonstrate here that PLD1 contributes to neurite outgrowth but also to dendrite branching and spine development. Yet, in apparent contradiction, PLD1 has recently been described to negatively regulate dendritic branching in hippocampal neurons (Zhu et al., 2012) . These findings were obtained from a different type of neuron, which may explain the discrepancy. But the discrepancy might instead stem from the method used to modify PLD1 expression levels, i.e., overexpression or silencing at 3 DIV. In the present study, PLD1 was genetically knocked down, implying that critical functions of PLD1 in early stages of neurite outgrowth could not be missed. It is also worth mentioning that our results are in line with the previous report showing that the GTPase RalB promotes branching through a pathway involving PLD (Lalli and Hall, 2005) .
We have previously reported that RSK2 phosphorylation of PLD1 is important for regulated exocytosis in chromaffin cells (Zeniou-Meyer et al., 2008 ) and for neurotransmission (Humeau et al., 2001) , indicating that this pathway may regulate various vesicular trafficking events in neurosecretory cells. In support of this hypothesis, PLD1 was shown to regulate intracellular trafficking of presenilin-1, a critical component of the ␥-secretase complex (Liu et al., 2009 ). Of particular interest, upregulation of PLD1 rescues impaired ␤APP trafficking to the plasma membrane and defects in neurite outgrowth capacity in a familial form of Alzheimer disease presenilin-1 mutant neurons (Cai et al., 2006) . It is thus tempting to speculate that the RSK2-phosphorylated form of PLD1 plays a key role in promoting vesicular delivery of key components for neuronal development and function.
We found that PLD1 KO also reduced the number of mature spines on dendrites. Many higher cognitive disorders, such as mental retardation, Rett syndrome, and autism, are associated with aberrant spine morphology and an altered long-term potentiation in neuron in culture (Pavlowsky et al., 2012) . Since dendritic spines are thought to represent a morphological correlate of neuronal plasticity, altered spine morphology may underlie or contribute to cognitive deficits seen in CLS. In agreement with this idea, we recently reported an alteration of long-term potentiation at cortical neuron synapses in the lateral amygdala (Zeniou-Meyer et al., 2010) . Signaling cascades that are important for cytoskeletal regulation may have an impact on spine morphology. Among those, the Rho GTPase signaling pathway, which is known to be involved in the regulation of the actin cytoskeleton, seems to play fundamental roles in the structural plasticity of dendritic spines (Svitkina et al., 2010) . The interplay between PLD1 and Rho GTPases has been shown in several cellular processes, but it remains to be established whether the altered dendrite and spine morphology observed in Pld1-KO mice, relies on an alteration of Rho activity. It is also worthwhile mentioning that the GTPase ARF6, an activator of PLD1 , has been reported to play a positive role in spine formation (Choi et al., 2006) , in line with the findings reported here.
PLD1 synthesizes PA, a bioactive lipid that has been proposed for a role in various trafficking events, including endocytosis and regulated exocytosis in various cell types ). In the process of neurite outgrowth, PA could stimulate the fusion of vesicles with the plasma membrane for the purpose of supplying membrane components to extending neurites, but also directly or indirectly regulate actin cytoskeletal organization, which is essential for the formation of filopodia and lamellipodia at growth cones. We did not find a significant modification of actin and tubulin staining in neurons cultured from Rsk2-KO and Pld1-KO mice (data not shown). However, we observed that RSK2 and PLD1 inhibitors significantly reduced the frequency of VAMP-7 vesicle fusion in growth cones, favoring the idea that RSK2-stimulated PLD1-induced PA production plays a role in VAMP-7 vesicle incorporation at the growing endings of developing neurites. The mechanism(s) by which PA promotes membrane fusion remains debated but it may be linked to its ability to generate membrane curvature (Zeniou-Meyer et al., 2007) , regulate phosphoinositol 4-5 bisphophate levels (Honda et al., 1999) , and/or modulate syntaxin-1 activity (Lam et al., 2008) . Our observation that expression of a PA sensor partially inhibits neurite outgrowth suggests that PA acts in part by recruiting key proteins at the vesicle fusion site.
Finally, it should be mentioned that the development in culture of neurons from Rsk2-KO and Pld1-KO models is delayed but not completely blocked. A possible explanation is that neurons compensate defects in the RSK2/PLD1 pathway by using alternative sources of PA. For instance, the PLD2 isoform has been also suggested to contribute to neurite outgrowth (Kanaho et al., 2009) . Alternatively in ribbon synapses, the PA involved in synaptic vesicle trafficking arises from lysophosphatidic acid acyltransferase activity (Schwarz et al., 2011) and the diacylglycerol (DAG)-kinases can also convert DAG into PA. Nevertheless, the present results support the idea that defects in PLD1 activity and fusogenic lipid synthesis could provide an explanation at the molecular level for abnormal growth and development of neural circuits leading to the learning and memory deficits observed after RSK2 loss-of-function mutations in animal models and CLS patients.
